Trump Backing for Bayer’s Monsanto Deal Buoys Investors: Bayer shares are up roughly 20% since Trump won election last November
This article is behind a paywall. Harvard affiliates can access it via Hollis+.
FRANKFURT—Investors in Bayer AG have taken heart from President Donald Trump’s apparent support for the German pharmaceuticals and chemicals firm’s planned $57 billion takeover of U.S. seed giant Monsanto Co. and are cautiously optimistic the deal will pass regulatory muster. [...]biotechnology food genetics international market pharmaceuticals regulation